Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI7510 for Prevention of RSV-associated Respiratory Illness in Older Adults
NCT02508194Phase 2Terminated
- Sponsor
- MedImmune
- Start
- Sep 2015
- Primary completion
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 7
01
Overview
A Phase 2 trial of MEDI7510 in respiratory syncytial virus infection (RSV), sponsored by MedImmune. Started Sep 2015; status: terminated.
02
Drugs
MEDI7510
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT02508194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02508194.